Press Release · Ortho Molecular Products
Ortho Molecular Products Named Exclusive Onboarding Partner of HANS, a Purpose-Built AI Platform for Functional Medicine
Distributed by AI AI List · Originally issued via PR Newswire
HANS is specifically designed around the complex, multi-system workflows of functional medicine to help reduce administrative burden for clinicians
STEVENS POINT, Wis. and CHICAGO, Nov. 10, 2026 — Ortho Molecular Products and HANS.FM today announced a strategic partnership naming Ortho Molecular Products as the exclusive onboarding partner for HANS, an intelligent clinical co-pilot built specifically for functional and integrative medicine.
Functional medicine practitioners deliver highly personalized care, but that depth often comes with significant administrative burden. Clinicians typically spend 30-60 minutes per patient on documentation and visit prep, and even up to 60-90 minutes for the most complex cases. In beta, HANS recorded a median time of 3.2 minutes to draft a complete SOAP note and approximately 29 seconds to generate a patient plan. By streamlining these workflows, HANS helps reduce administrative burden, allowing more capacity for patient care.
"For nearly 40 years, Ortho Molecular Products has equipped practitioners with evidence-based tools, education and resources that advance functional and integrative medicine," said Gary Powers, CEO at Ortho Molecular Products. "Serving as the exclusive onboarding partner of HANS extends our commitment, giving clinicians the infrastructure they need to work more efficiently and helping them keep focus on their patients' outcomes."
Developed alongside practicing clinicians, HANS is built on a physician-developed, closed-loop functional medicine knowledge library containing more than 5,000 citations across 109 Clinical Intelligence Guides. Unlike open-ended AI tools that draw from broad internet sources, HANS provides transparency behind its outputs and allows practitioners to review or override AI-generated information before it enters the patient chart. The platform is also designed to support specialized laboratories, personalized protocols and multi-system cases, helping practitioners efficiently synthesize large amounts of information.
"Our mission is to reduce the cognitive and administrative burden on practitioners with technology that supports, rather than replaces, clinical judgment," said Andrew Le, MD, CEO of HANS. "Through Ortho Molecular Products' trusted practitioner network and support capabilities, we can bring these purpose-built workflows to more functional medicine clinicians."
HANS is now available in the U.S. and is supported by Ortho Molecular Products' exclusive onboarding services. To learn more about available plans, pricing and product capabilities, visit HANS.fm.
Press contact: [email protected]
SOURCE Ortho Molecular Products
About Ortho Molecular Products
For nearly 40 years, Ortho Molecular Products has partnered with clinicians who reject assembly-line care to transform medicine through evidence-based nutritional solutions. Combining cGMP-certified manufacturing, rigorous quality control, and practitioner-exclusive distribution, Ortho Molecular Products provides the therapeutic support clinicians rely on for individualized care. The company remains committed to advancing functional medicine through clinical education, service excellence, and practical practice support. Learn more at orthomolecularproducts.com.
About HANS
HANS is an intelligent clinical co-pilot engineered specifically for the distinct demands of functional and integrative medicine. By handling the heavy lifting of pre-consult synthesis, longitudinal lab cross-correlation, draft SOAP notes, and protocol management, HANS eliminates administrative drag and lowers cognitive load. Designed to mirror practical clinical workflows, HANS restores practice flow so clinicians can focus on critical reasoning, strong therapeutic alliances, and transformative patient outcomes. Learn more at HANS.fm.